This interview is part of a series in which experts discuss key aspects of the malaria challenge– innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion, what would be positive game changers … Read More
#GBCtalksmalaria Interview Series
Tremendous progress has been made in the fight to end malaria. Seventeen countries have reduced malaria cases to the point where it is no longer endemic – and eight of these have fully eliminated malaria. Since 2000, malaria prevention and treatment programs have saved an estimated 4.3 million lives. Companies have helped to both accelerate this progress and shape malaria … Read More
Corporate Leadership in the Fight to End Malaria
Tremendous progress has been made in the fight to end malaria. Seventeen countries have reduced malaria cases to the point where it is no longer endemic – and eight of these have fully eliminated malaria. Since 2000, malaria prevention and treatment programs have saved an estimated 4.3 million lives. Companies have helped to both accelerate this progress and shape malaria … Read More
Mapping Tool Seeks to Mobilize New and Efficient Investments in Malaria
Malaria remains a health and economic challenge for Nigeria. As a country, it carries the largest malaria burden in the world with over 100 million cases and 300,000 deaths due to the disease annually (NMEP Strategic Plan for 2014-2020). The negative impact affects all sectors, from high absenteeism in school, to decreased worker productivity and increased insurance costs. An Ambitious … Read More
CAMA Co-Chair Chevron Launches Malaria Program in Lagos State, Nigeria
Chevron Corporation’s local business unit, Chevron Nigeria Limited (CNL), in collaboration with the Nigerian National Petroleum Corporation has launched the Roll Back Malaria (RBM) program in Lagos State to support the State health authorities in addressing the considerable impact of malaria on the local population. Malaria is endemic in Lagos State with over 540,000 cases reported in 2014. In metropolitan … Read More
On the Horizon: Private Sector Innovations for Malaria Elimination | An ASTMH Private Sector Reception
In conjunction with the 64th ASTMH Annual Meeting, the Corporate Alliance on Malaria in Africa (CAMA) will welcome private sector representatives and special guests for a dinner reception. The theme for the evening is, “On the Horizon: Private Sector Innovations for Malaria Elimination”. This event is hosted by Ernesto de la Torre, Co-Chair, CAMA and Global Public Health Coordinator, Chevron … Read More
CAMA Partners with Etisalat and National Malaria Elimination Programme on World Mosquito Day Advocacy Campaign in Nigeria
Each year on August 20th the world celebrates World Mosquito Day. This year, as a result of its 2016 Annual Technical Forum, CAMA formed a partnership with Etisalat Nigeria, the National Malaria Elimination Programme of Nigeria and HACEY Health Initiative, on a Nigeria-wide World Mosquito Day Campaign. The campaign spanned social media, print media and radio/TV slots with messages on … Read More
The Road to 2020: Media Coverage
In addition to the social media reach by #EndMalaria2020, the 2015 CAMA Annual Technical Forum, The Road to 2020: Mobilizing the Private Sector in Nigeria’s Fight Against Malaria, received wide media coverage within Nigeria. Read more about the event on the following outlets: Business day If you want to improve your productivity, then you need to get malaria under control. The road to … Read More
Isaiah Owalabi, CAMA Program Manager, Receives Queen’s Young Leaders Award
GBCHealth’s Atlas Corps Fellow, Isaiah Owolabi, who has been managing the Corporate Alliance on Malaria in Africa (CAMA) for the past year, was honored to receive a Queen’s Young Leaders Award. The Queen’s Young Leaders Programme discovers, celebrates and supports exceptional young people from across the Commonwealth. Award winners, aged 18-29, are recognized by The Queen for taking the lead … Read More
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
24 July 2015 | Via GSK WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as … Read More